Roivant Sciences (ROIV) Financial Statements & Analysis

Roivant Sciences (ROIV) Income Statement

Roivant Sciences reported revenue of $8.26M in fiscal 2026 (fiscal year ended Mar 31, 2026), down 71.6% from $29.05M a year earlier. Roivant Sciences posted a net loss of $299.77M, compared with a net loss of $171.98M a year earlier. Gross margin was 84.4% and operating margin -6235.7%. In the most recent quarter, Q1 fiscal 2027 (ended Jun 30, 2026), revenue was $1.44M, down 33.5% from the same quarter a year earlier.

Roivant Sciences Income Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Roivant Sciences Ltd. income statement - Annual data in billions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue & Gross Profit
Revenue	0.01	0.03	0.03	0.03	0.06	0.02	0.07
Cost of Revenue	0.68	0.55	0.00	0.46	0.01	0.00	0.00
Gross Profit	0.01	0.03	0.03	0.05	0.05	0.02	0.07
Operating Expenses
Research & Development	0.68	0.55	0.44	0.62	0.48	0.83	0.26
Selling, General & Administrative	0.61	0.57	0.42	0.38	0.78	0.26	0.34
Operating Expenses	0.52	1.03	0.86	1.22	1.26	1.09	0.60
Operating Income	-0.52	-1.00	-0.82	-1.18	-1.21	-1.07	-0.53
Other Income/Expense
Interest Income	0.18	0.26	0.15	0.03	0.00	0.00	0.02
Interest Expense	0.00	0.00	0.03	0.03	0.01	0.00	0.01
Other Income/Expense	0.25	0.32	5.25	-0.05	0.29	0.17	-0.03
Income
Income Before Tax	-0.26	-0.68	4.57	-0.88	-0.92	-0.90	-0.56
Income Tax Expense	0.13	0.05	0.02	0.01	0.00	0.00	0.01
Net Income	-0.30	-0.17	4.35	-1.01	-0.85	-0.81	1.20
Net Income - Continuous Operations	-0.30	-0.73	4.55	-0.89	-0.92	-0.81	1.20
Net Income - Discontinued Operations	-	0.37	-0.32	-0.23	-	-	-
EBITDA	-1.28	-1.07	-0.80	-0.79	-0.91	-1.07	-0.55
EBIT	-1.28	-1.09	-0.82	-0.81	-0.92	-1.07	-
Depreciation & Amortization	0.00	0.01	0.02	0.02	0.01	0.00	0.00
Earnings Per Share
Basic EPS	-	-	5.00	-1.00	-1.00	-1.00	2.00
Diluted EPS	-1.00	-	5.00	-1.00	-1.00	-1.00	2.00
Basic Shares Outstanding	0.69	0.73	0.78	0.71	0.67	0.63	0.68
Diluted Shares Outstanding	0.69	0.73	0.83	0.71	0.67	0.63	0.68

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Roivant Sciences Financial Statements

What was Roivant Sciences's revenue in fiscal 2026?

Roivant Sciences reported revenue of $8.26M in fiscal 2026 (fiscal year ended Mar 31, 2026). That was down 71.6% from $29.05M a year earlier.

Is Roivant Sciences profitable?

No. Roivant Sciences reported a net loss of $299.77M in fiscal 2026. In fiscal 2025 it lost $171.98M.

What is Roivant Sciences's operating margin?

Roivant Sciences's operating income was −$515.07M on revenue of $8.26M in fiscal 2026, an operating margin of -6235.7%, compared with -3453.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition